High frequency of central nervous system involvement in transformed Waldenström macroglobulinemia.

Autor: Durot E; Department of Hematology, University Hospital of Reims, Reims, France.; UFR Médecine, Reims, France., Kanagaratnam L; Department of Research and Public Health, University Hospital of Reims, Reims, France.; UR 3797, Vieillissement, Fragilité (VieFra), Faculty of Medicine, University of Reims Champagne-Ardenne, Reims, France., Zanwar S; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN., Toussaint E; Department of Hematology, University Hospital of Strasbourg, Strasbourg, France., Kastritis E; Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece., D'Sa S; University College London Hospitals (UCLH) NHS Foundation Trust, London, United Kingdom., Alcoceba M; Department of Hematology, University Hospital of Salamanca (HUS/IBSAL), CIBERONC and Cancer Research Institute of Salamanca-IBMCC (USAL-CSIC), Salamanca, Spain., Tomowiak C; Department of Hematology and CIC U1402, University Hospital of Poitiers, Poitiers, France., Hivert B; Department of Hematology, Hospital of Lens, Lens, France., Protin C; Department of Hematology, IUCT Oncopole, Toulouse, France., Abeykoon JP; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN., Vos JMI; Amsterdam University Medical Center (UMC) and LYMMCARE, Amsterdam, The Netherlands., Michallet AS; Department of Hematology, Léon Bérard Center, Lyon, France., Rodier C; Department of Hematology, University Hospital of Reims, Reims, France.; UFR Médecine, Reims, France., Dupuis J; Lymphoid Malignancies Unit, Henri Mondor Hospital, Créteil, France., Leprêtre S; Inserm U1245 and Department of Hematology, Henri Becquerel Center and Normandie University UNIROUEN, Rouen, France., Merabet F; Department of Hematology, André Mignot Hospital, Versailles, France., Roussel X; Department of Hematology, University Hospital of Besançon, Besançon, France., Zini JM; Department of Hematology, Saint-Louis Hospital, Paris, France., Regny C; Department of Hematology, University Hospital of Grenoble, Grenoble, France., Patel A; University College London Hospitals (UCLH) NHS Foundation Trust, London, United Kingdom., Morel P; Department of Hematology, University Hospital of Amiens, Amiens, France., Roos-Weil D; Department of Hematology, Sorbonne University, Pitié-Salpêtrière Hospital, APHP Paris, France; and., Treon SP; Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Dimopoulos MA; Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece., Garcia-Sanz R; Department of Hematology, University Hospital of Salamanca (HUS/IBSAL), CIBERONC and Cancer Research Institute of Salamanca-IBMCC (USAL-CSIC), Salamanca, Spain., Kapoor P; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN., Castillo JJ; Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Delmer AJ; Department of Hematology, University Hospital of Reims, Reims, France.; UFR Médecine, Reims, France.

Publikováno v: Blood advances [Blood Adv] 2022 Jun 28; Vol. 6 (12), pp. 3655-3658.

Early assessment of the safety and immunogenicity of a third dose (booster) of COVID-19 immunization in Chinese adults.

Autor: Zhang, Yuntao, Yang, Yunkai, Qiao, Niu, Wang, Xuewei, Ding, Ling, Zhu, Xiujuan, Liang, Yu, Han, Zibo, Liu, Feng, Zhang, Xinxin, Yang, Xiaoming

Publikováno v: Frontiers of Medicine; Feb2022, Vol. 16 Issue 1, p93-101, 9p